Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39 | -50 | 800 | -350 | -80 |
| Depreciation Amortization | N/A | 0 | 0 | 30 | 40 |
| Other Working Capital | -1 | -6 | 30 | -3 | -220 |
| Other Operating Activity | 0 | -4 | -500 | 23 | 10 |
| Operating Cash Flow | $-41 | $-60 | $330 | $-300 | $-250 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | 0 | 0 | -5 |
| Other Investing Activity | 0 | 0 | -350 | -10 | -3 |
| Investing Cash Flow | $N/A | $0 | $-350 | $-10 | $-8 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 40 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 370 | -1 | -50 |
| Financing Cash Flow | $40 | $0 | $370 | $-1 | $-50 |
| Beginning Cash Position | 2 | 60 | 220 | 550 | 870 |
| End Cash Position | 1 | 2 | 580 | 220 | 550 |
| Net Cash Flow | $-1 | $-60 | $350 | $-320 | $-320 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41 | -60 | 330 | -300 | -250 |
| Free Cash Flow | -41 | -60 | 330 | -300 | -250 |